K., & Hassan, A
In recent years, Ozempic (semaglutide) has gained significant attention for its effectiveness in promoting weight loss alongside its primary use in managing type 2 diabetes
Semaglutide alters appetite, gastric emptying, and metabolic signaling, and these shifts translate into measurable improvements in glucose control, lipids, hydration, and, in some cases, liver or kidney markers
It is also frequently incorporated into post-cycle and hormone-recovery protocols to support endogenous testosterone signaling and hormonal normalization under medical supervision
Low-dose aspirin (typically 81 mg daily in the US) should be considered for secondary prevention in patients with prior cardiovascular events, while primary prevention use requires individualized assessment of bleeding risk versus benefit
1 The standards for diabetes management from the American Diabetes Association (ADA) have evolved significantly in recent years, and their 2025 standards recommend SGLT2 inhibitors and GLP1 RAs as first-line, glucose-lowering medications for all patients with diabetes